MedTrace Logo

Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases

NCT04420637 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1366

Last updated 2023-01-12

No results posted yet for this study

Summary

This study aims primarily

1. to assess the frequency, nature and outcome of liver disease caused or associated with COVD-19 Furthermore, the study also aims
2. to assess the impact of COVID-19 on patients with chronic liver disease or after liver transplantation (frequency of infections, course of disease, outcome)
3. to assess, whether quarantine measures impact on the rate of decompensation of liver cirrhosis
4. to assess whether the intake of antiviral drugs protects against SARS-CoV-2 infection or COVID disease.

Conditions

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-15
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04420637 on ClinicalTrials.gov